To Get Help Now
Click Here
 
Today's Date:

Fosamax Lawsuit Accuses Manufacturer of Concealing Unreasonably Dangerous Risks

AddThis Social Bookmark Button

Josephine P. Naccio, Louisiana,  filed a personal injury lawsuit against Merck Sharp & Dohme Corp, the manufacturers of the drug Fosamax, regarding over-promotion of the drug for alleged non-approved or “off-label” uses.

Naccio accuses Merck Sharp & Dohme Corp of concealing the “unreasonably dangerous risks” , after she sustained an unexplained femur fracture.  The plaintiff stated that she would not have taken Fosamax if she had been aware of the side effects and risks caused by long term use of the drug.

In her lawsuit, Naccio also accuses the manufacturers of Fosamax with failing to conduct post-marketing surveillance.

In 2010, the FDA issued an alert regarding the unusual femur fractures that were being reported in patients taking bisphosphonates like Fosamax. The FDA then mandated that manufacturers alert users to the possible association of thigh fractures as a possible side effect of use on drug labels.

Bisphosphonates like Fosamax have been associated with numerous other side effects including  esophageal cancer, atrial fibrillation, severe musculoskeletal pain and osteonecrosis of the jaw or dead jaw syndrome.

breakinglawsuitnews.com disclaimer: This article: Fosamax Lawsuit Accuses Manufacturer of Concealing Unreasonably Dangerous Risks was posted on Thursday, April 28th, 2011 at 8:03 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.